Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

318
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
318
Tissue Transplantation01:24

Tissue Transplantation

352
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
352
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

4.0K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.0K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Associations between abuse, neglect, and at-risk family interactions with adolescent psychiatric disorders.

Child abuse & neglect·2026
Same author

Influence of at-risk family interactions on the course of psychiatric care in adolescence.

European child & adolescent psychiatry·2024
Same author

Observation of WZγ Production in pp Collisions at sqrt[s]=13  TeV with the ATLAS Detector.

Physical review letters·2024
Same author

Search for Dark Photons in Rare Z Boson Decays with the ATLAS Detector.

Physical review letters·2024
Same author

Sequential vs myeloablative vs reduced intensity conditioning for patients with myelodysplastic syndromes with an excess of blasts at time of allogeneic haematopoietic cell transplantation: a retrospective study by the chronic malignancies working party of the EBMT.

Bone marrow transplantation·2023
Same author

Observation of Single-Top-Quark Production in Association with a Photon Using the ATLAS Detector.

Physical review letters·2023

相关实验视频

Updated: Jun 18, 2025

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
06:39

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome

Published on: October 3, 2018

9.8K

对于MDS移植的调节方案的当前挑战

A B Notarantonio1, M Robin2, M D'Aveni1

  • 1Hematology Department, University Hospital of Nancy, France; CNRS 7365, IMoPA, University of Lorraine, F-54000, France.

Blood reviews
|August 1, 2024
PubMed
概括

异构干细胞移植是高风险骨髓发育综合征 (MDS) 的唯一治愈选择. 优化调节方案以平衡疗效和毒性对于更好的患者结果至关重要.

科学领域:

  • 血液学 血液学 血液学
  • 在瘤学瘤学.
  • 免疫学 免疫学 免疫学

背景情况:

  • 骨髓质疏松症候群 (MDS) 是一种具有异质临床表现的克隆性疾病.
  • 高风险的MDS患者由于急性髓性白血病的高进展率而面临不良预后.
  • 全基性造血干细胞移植 (HSCT) 通过移植与MDS效应提供了持久的疾病控制.

研究的目的:

  • 审查和评价高风险MDS患者的HSCT调节方案的研究.
  • 评估强化条件化的策略,以准恶性克隆.
  • 为了确定最佳的调节方案,平衡疗效和毒性.

主要方法:

  • 对回顾性和前性研究进行系统审查.
  • 对调节方案强度和药物组合的分析.
  • 对毒性概况和治疗结果的评估.

主要成果:

  • 由于对老年MDS患者的毒性担忧,强化调节方案仍在讨论中.
  • 已经探索了新的药物,以改善克隆控制,而不会增加毒性.
  • 现有研究的证据在定义理想治疗方案方面存在局限性.

结论:

关键词:
异性干细胞移植 异性干细胞移植调节强度的调节强度.骨髓分裂性综合征 骨髓分裂性综合征

更多相关视频

Busulfan as a Myelosuppressive Agent for Generating Stable High-level Bone Marrow Chimerism in Mice
11:25

Busulfan as a Myelosuppressive Agent for Generating Stable High-level Bone Marrow Chimerism in Mice

Published on: April 1, 2015

13.3K
Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis
08:00

Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis

Published on: May 26, 2021

12.4K

相关实验视频

Last Updated: Jun 18, 2025

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
06:39

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome

Published on: October 3, 2018

9.8K
Busulfan as a Myelosuppressive Agent for Generating Stable High-level Bone Marrow Chimerism in Mice
11:25

Busulfan as a Myelosuppressive Agent for Generating Stable High-level Bone Marrow Chimerism in Mice

Published on: April 1, 2015

13.3K
Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis
08:00

Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis

Published on: May 26, 2021

12.4K
  • 高风险的MDS接受HSCT的最佳调节方案需要进一步划分.
  • 要平衡强烈的抗白血病效应与可接受的毒性之间的需求至关重要.
  • 未来的研究应该专注于开发更安全,更有效的调节策略.